Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)

China flag China · Delayed Price · Currency is CNY
12.18
-0.09 (-0.73%)
Feb 24, 2026, 10:15 AM CST
Market Cap16.08B +19.4%
Revenue (ttm)5.38B -1.0%
Net Income420.20M
EPS0.29
Shares Out1.47B
PE Ratio42.15
Forward PE20.60
Dividend0.25 (2.07%)
Ex-Dividend Daten/a
Volume1,132,800
Average Volume4,344,391
Open12.33
Previous Close12.27
Day's Range12.08 - 12.33
52-Week Range9.72 - 14.34
Beta0.49
RSI44.57
Earnings DateMar 31, 2026

About SHE:002399

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. provides pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. It operates in four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization (CDMO), and Others. The company offers finished dose pharmaceutical products, such as prolongin, inhixa, neoparin, and heparin and enoxaparin sodium injections; API products, including heparin and enoxaparin sodium APIs; and pan... [Read more]

Sector Healthcare
Founded 1998
Employees 1,926
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002399
Full Company Profile

Financial Performance

Financial Statements